Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients Bo Kyung KimKyung Taek HongHyoung Jin Kang Original Article Open access 10 April 2024 Pages: 2051 - 2058
Could it be VEXAS? Hippolyte GuerineauMilena KohnAurélie Cabannes-Hamy Case Report 09 April 2024 Pages: 2169 - 2171
Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century Zhengjiu CuiFei LuoYueli Pan Review 09 April 2024
Thiotepa-busulfan-fludarabine-based conditioning as a promising approach prior to allogeneic hematopoietic stem cell transplantation in patients with blastic plasmacytoid dendritic cell neoplasm Xianbo HuangShasha WangJiejing Qian Case Report 08 April 2024 Pages: 2165 - 2168
Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China Lan LuoYang JiaoHongmei Jing Research 06 April 2024 Pages: 2073 - 2087
Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia Antonella MeloniLaura PistoiaFilippo Cademartiri Original Article 06 April 2024 Pages: 1887 - 1896
Quality of life after immune suppressive therapy in aplastic anemia Iris N. LommerseChris HinnenJennifer M.-L. Tjon Original Article Open access 05 April 2024 Pages: 2113 - 2121
Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma Takumi KondoKeito OharaKensuke Kojima Letter to the Editor 03 April 2024
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study Lucía Pérez-LamasRaquel de Paz AriasValentín García-Gutiérrez Research 03 April 2024
Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report Jiawen WangHan ZhuKourong Miao Case Report 01 April 2024 Pages: 1775 - 1777
The role of therapeutic plasma exchange in plasma cell disorders Danai DimaJack Khouri Review Open access 01 April 2024
Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians Cordula GebelIsabel KruschelUlrich Wedding Research Open access 28 March 2024 Pages: 1753 - 1763
Comparison of rabbit ATLG and ATG for GVHD prophylaxis in hematological malignancies with haploidentical hematopoietic stem cell transplantation Zhengqin TianQihang ManJingbo Wang Research 28 March 2024 Pages: 1729 - 1736
Correction to: Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia Yue ChenMengge PanPeipei Xu Correction 27 March 2024 Pages: 1801 - 1801
Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation Miao ZhouTongyu LiGuifang Ouyang Original Article 27 March 2024 Pages: 1697 - 1704
Novel methyltransferase G9a inhibitor induces ferroptosis in multiple myeloma through Nrf2/HO-1 pathway Yu ZhangXiaoshun WangLijuan Wang Research 27 March 2024
The influence of hospital volume and physician volume on early mortality in acute promyelocytic leukemia patients Chia-Ying WuChiu-Mei YehChia-Jen Liu Original Article Open access 26 March 2024 Pages: 1577 - 1586
The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study Haixia FuXuan Caion behalf of the Collaborative ITP Working Group Research 25 March 2024 Pages: 1549 - 1559
Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study Alexander RöthWilma BarcelliniIlene C. Weitz Correction Open access 23 March 2024 Pages: 1803 - 1803
Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia Eduardo J. Bardón-CanchoJosé Manuel Marco-SánchezElena Cela Original Article Open access 23 March 2024 Pages: 1525 - 1539
XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway Xiaoya CaiYing LiuDengju Li Research 23 March 2024
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report Shuhei KurosawaTakako YokotaTomonori Nakazato Correspondence 21 March 2024 Pages: 1779 - 1781
Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation Yoshihiro UmezawaKota YoshifujiTakehiko Mori Research 21 March 2024 Pages: 1737 - 1744
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report Jian-hui ZhangHui ChenHong Li Case Report 20 March 2024 Pages: 1765 - 1774
Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study Khaled M. MusallamSusanna Barellathe Webthal® project Research 19 March 2024
Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation Kazuya TakemuraMika NakamaeHirohisa Nakamae Original Article 18 March 2024 Pages: 1705 - 1715
Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia Xiao-Tong HuangChan-Juan WangZhi-Gang Li Research 18 March 2024
The application of JAK inhibitors in the peri-transplantation period of hematopoietic stem cell transplantation for myelofibrosis Zerong WangXuelian JinXinchuan Chen Review Article Open access 18 March 2024
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study Naokazu NakamuraNobuyoshi Arimathe Kansai Myeloma Forum Research 16 March 2024
Nomogram predictive models for adult patients with acute lymphoblastic leukaemia based on real-world treatment outcomes Yi ChenYanxin ChenJianda Hu Research 14 March 2024
The impact of statin use on disease-related symptoms in patients with chronic myeloproliferative neoplasms Hrvoje HolikMarko LucijanićIvan Krečak Correspondence 13 March 2024 Pages: 1783 - 1785
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study F. PalandriG. AuteriG. A. Palumbo Research Open access 13 March 2024 Pages: 1931 - 1940
Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation Te-Lin HsuChun-Kuang TsaiChia-Jen Liu Original Article Open access 13 March 2024
Spotlight on the real-world treatment of CML pts in Germany: a retrospective survey in private oncology practices Georg-Nikolaus FrankeGunnar LoeweKathleen Jentsch-Ullrich Original Article Open access 12 March 2024 Pages: 1569 - 1575
Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection Yuanfang LiSanjing LiDao Wang Original Article 12 March 2024 Pages: 1541 - 1547
Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies? Pasquale NiscolaValentina GianfeliciPaolo de Fabritiis Correspondence 09 March 2024 Pages: 1787 - 1788
Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020 Marina Xavier TeixeiraAdriano Max Moreira ReisCristiane Aparecida Menezes de Pádua Research 09 March 2024
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group Gabriel ScheubeckMartin Hoffmannon behalf of the German Lymphoma Alliance (GLA) Original Article Open access 09 March 2024
Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study Xu SunHe LiTing Niu Research 09 March 2024
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population Emily L. GillChristian M. GillColleen McEvoy Research Open access 08 March 2024 Pages: 1745 - 1752
Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan Mendy ter AvestSaskia M.C LangemeijerRob ter Heine Original Article Open access 08 March 2024
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors Wenjie LiYiming FuWei Wang Research 08 March 2024
Mutations of epigenetic modifier genes predict poor outcome in adult acute lymphoblastic leukemia Jiawang OuShiyu DengHongsheng Zhou Research 07 March 2024
Acute myeloid leukemia with rare recurring translocations—an overview of the entities included in the international consensus classification Synne D. RørvikSynne TorkildsenTor Henrik Anderson Tvedt Review Article Open access 06 March 2024 Pages: 1103 - 1119
Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia Jia ChenMing-nan JiaXin-xin Cao Research 06 March 2024
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study Caroline DartigeasAnne Quinquenelon behalf of the FIRE Investigators Group Research Open access 06 March 2024
Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma Hongpeng DuanQiuhui JiangZhijuan Lin Review 06 March 2024
Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome–positive acute lymphoblastic leukaemia Lijuan HuZongru LiQian Jiang Research 05 March 2024
Intramedullary leukocytoclastic vasculitis and neutrophil extracellular trap (NET) formation in POEMS syndrome Wiebke AderholdBenjamin LenzInes Gütgemann Letter to the Editor Open access 04 March 2024 Pages: 1415 - 1417
